Jeff Conn
Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)
Department of Pharmacology
We study the of specific neurotransmitter receptors in regulation of transmission and signaling in brain circuits involved in psychiatric and neurological disorders. From this, we endeavor to develop new treatment strategies for brain disorders and engage in full drug discovery efforts aimed at advancing new drug candidates into clinical development with industry partners.
We study the of specific neurotransmitter receptors in regulation of transmission and signaling in brain circuits involved in psychiatric and neurological disorders. From this, we endeavor to develop new treatment strategies for brain disorders and engage in full drug discovery efforts aimed at advancing new drug candidates into clinical development with industry partners.
Keywords: Schizophrenia , major depression , Parkinson's disease , drug discovery , muscarinic acetylcholine receptors , metabotropic glutamate receptors
Research Area: Cell Signaling , Chemical Biology , Drug Design , Neurodegeneration and Neuroinflammation , Synaptic Function & Neuroendocrinology